Mannatech Inc (NASDAQ:MTEX) Institutional Investor Sentiment Is 1.29

September 16, 2018 - By Adrian Mccoy

Mannatech, Incorporated (NASDAQ:MTEX) Logo

Sentiment for Mannatech Inc (NASDAQ:MTEX)

Mannatech Inc (NASDAQ:MTEX) institutional sentiment decreased to 1.29 in Q2 2018. Its down -0.21, from 1.5 in 2018Q1. The ratio dropped, as 9 investment managers opened new and increased stock positions, while 7 sold and reduced their holdings in Mannatech Inc. The investment managers in our partner’s database now own: 548,157 shares, down from 583,686 shares in 2018Q1. Also, the number of investment managers holding Mannatech Inc in their top 10 stock positions was flat from 0 to 0 for the same number . Sold All: 2 Reduced: 5 Increased: 4 New Position: 5.

Mannatech, Incorporated operates as a wellness solution provider. The company has market cap of $49.85 million. It develops and sells nutritional supplements, topical, skin care and anti-aging products, and weight-management products. It currently has negative earnings. The firm markets its products through network marketing channel in the Americas, Europe/the Middle East/Africa, and the Asia/Pacific.

The stock increased 2.98% or $0.6 during the last trading session, reaching $20.75. About 10,889 shares traded or 99.21% up from the average. Mannatech, Incorporated (NASDAQ:MTEX) has risen 43.06% since September 16, 2017 and is uptrending. It has outperformed by 27.44% the S&P500.

Bridgeway Capital Management Inc holds 0.01% of its portfolio in Mannatech, Incorporated for 61,509 shares. Spark Investment Management Llc owns 11,900 shares or 0.01% of their US portfolio. Moreover, Acadian Asset Management Llc has 0% invested in the company for 43,743 shares. The North Carolina-based Bank Of America Corp De has invested 0% in the stock. Blackrock Inc., a New York-based fund reported 78,347 shares.

Since January 1, 0001, it had 2 insider purchases, and 0 selling transactions for $34,424 activity.

Mannatech, Incorporated (NASDAQ:MTEX) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: